Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$9 Mln
Revenue (TTM)
$22 Mln
Net Profit (TTM)
$-42 Mln
ROE
-1 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.7
Industry P/E
25
EV/EBITDA
-1.9
Div. Yield
0 %
Debt to Equity
0.4
Book Value
$--
EPS
$-5.7
Face value
--
Shares outstanding
9,092,518
CFO
$-67.10 Mln
EBITDA
$-81.90 Mln
Net Profit
$-239.65 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
DSS Inc (DSS)
| 3.6 | 1.2 | -1.9 | 12.4 | -37.2 | -58.5 | -47.5 |
|
BSE Sensex*
| -11.6 | -10.6 | -11.4 | -0.6 | 8.9 | 8.8 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
DSS Inc (DSS)
| 3.1 | -62.2 | -26.8 | -75.6 | -89.2 | -30.9 | -58.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
DSS Inc (DSS)
|
1.0 | 9.2 | 22.1 | -42.1 | -206.6 | -225.2 | -- | 0.7 |
| 124.2 | 8,441.9 | 3,777.2 | 392.8 | 14.4 | 15.3 | 21.8 | 3.1 | |
| 101.4 | 12,131.1 | 12,365.0 | 734.0 | 12.9 | 25.5 | 16.5 | 3.9 | |
| 9.6 | 2,877.6 | 8,617.0 | 444.0 | 9.4 | 14 | 6.6 | 0.9 | |
| 64.5 | 3,846.5 | 4,290.7 | 840.0 | 9.0 | 33.6 | 27.9 | 1.3 | |
| 35.9 | 19,722.7 | 24,896.0 | -3,516.0 | -12.0 | -30.6 | -- | 1.3 | |
| 209.4 | 19,300.1 | 8,989.3 | 768.9 | 12.3 | 17.1 | 25 | 4.2 | |
| 3.5 | 290.6 | 395.0 | -38.3 | -6.2 | -7.1 | -- | 0.5 | |
| 52.3 | 5,259.7 | 7,518.8 | 396.4 | 13.3 | 13.5 | 9 | 1.4 |
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom... folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, the company focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engages in nonbanking activities related to banking, such as loan syndication, mortgage banking, trust and escrow, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services; and operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as lists and operates as a digital asset on secondary market. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York. Read more
Executive Chairman of the Board
Mr. Fai Heng Chan
Executive Chairman of the Board
Mr. Heng Fai Chan
Headquarters
West Henrietta, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of DSS Inc (DSS) is $0.96 (NYSE) as of 18-Mar-2026 16:10 EDT. DSS Inc (DSS) has given a return of -37.24% in the last 3 years.
Since, TTM earnings of DSS Inc (DSS) is negative, P/E ratio is not available.
The P/B ratio of DSS Inc (DSS) is 0.67 times as on 13-Mar-2026, a 47 discount to its peers’ median range of 1.27 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-0.14
|
0.31
|
|
2023
|
-0.01
|
0.01
|
|
2022
|
-0.31
|
0.15
|
|
2021
|
-1.44
|
0.30
|
|
2020
|
63.86
|
1.66
|
The 52-week high and low of DSS Inc (DSS) are Rs 1.90 and Rs 0.73 as of 19-Mar-2026.
DSS Inc (DSS) has a market capitalisation of $ 9 Mln as on 13-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in DSS Inc (DSS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.